<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>PSYCHONEUROLOGICAL DISORDERS OBSERVED IN PARKINSON'S DISEASE.</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Sa'dullayeva Go‘zaloy Bahtiyor</mods:namePart><mods:namePart type="family">qizi</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Xo‘shmurodova Mexrigiyo</mods:namePart><mods:namePart type="family">Allayorovna</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Hakimov Ilyos</mods:namePart><mods:namePart type="family">Baxtiyorovich</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>This article aims to systematize psychoneurological disturbances in Parkinson’s disease and provide an integrative interpretation of their pathogenesis. A narrative-systematic literature review combined with comparative clinical conceptualization was applied across international and regional sources. Results indicate that cognitive decline, depression, anxiety, apathy, psychosis, and sleep disorders form interrelated clinical clusters. The contribution lies in clarifying how non-motor symptoms should be incorporated into clinical decision-making in Parkinson’s disease.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-06-04</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>